Skip to main content
Clinical Trials/NCT04581850
NCT04581850
Recruiting
Not Applicable

Assessment of Sleep Disturbance as a Biomarker of Disease Activity in a Military Population With Posttraumatic Stress Disorder

Direction Centrale du Service de Santé des Armées6 sites in 1 country190 target enrollmentOctober 16, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post-traumatic Stress Disorder
Sponsor
Direction Centrale du Service de Santé des Armées
Enrollment
190
Locations
6
Primary Endpoint
Proportion of subjects with a Sleep Efficiency Index (SEI) < 80%.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Post-Traumatic Stress Disorder (PTSD) is a public health problem due to both its chronic nature and the low response rate to conventional therapies.

Sleep disorders are the first cause of complaint in patients with PTSD due to night awakenings, difficulty to fall asleep and nightmares.

According to a part of the scientific community, replicative traumatic nightmares represent PTSD's basis mechanism. Traumatic nightmares generate disabling symptoms such as anxiety reactions, while maintaining the symptoms by depriving the individual of good quality sleep. Traumatic nightmares may thus be a sign of PTSD seriousness and chronicity, although their physiological basis remain poorly known.

In the military population, which is highly exposed to psychological traumatism, PTSD prevalence is very high and is associated with severe intensity patterns, a very high frequency of replicative nightmares and a low response to conventional therapies.

Registry
clinicaltrials.gov
Start Date
October 16, 2020
End Date
October 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Direction Centrale du Service de Santé des Armées
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Military or former military
  • Age between 18 and 65 years old
  • PTSD group : with a PTSD diagnosis
  • Control group : without any sleep, psychiatric or neurologic pathology

Exclusion Criteria

  • Diagnosis of progressive psychiatric pathology prior to the traumatic event responsible for PTSD
  • Sleep pathology prior to the traumatic event responsible for PTSD
  • Neurological pathology or severe head injury within the last 3 years

Outcomes

Primary Outcomes

Proportion of subjects with a Sleep Efficiency Index (SEI) < 80%.

Time Frame: 1 month after enrollment

The sleep efficiency index (SEI) is defined by the ratio TST/TIB with TST being Total Sleep Time and TIB being Time In Bed. TST and TIB will be assessed objectively, at home, using a connected headband (DREEM®, Rythm Paris). A Sleep Efficiency Index (SEI) \< 80% is considered to be a poor quality, low-efficiency night.

Study Sites (6)

Loading locations...

Similar Trials